We now find ourselves months into the COVID-19 pandemic since it was first declared on March 11th, 2020. As time moves forward, the global research community continues to devote effort and resources towards better understanding this disease. One important focus is to better understand the risk of transmission of the SARS-CoV-2 virus from infected to uninfected individuals.
Corticosteroids, also sometimes referred to as just ‘steroids’, are an important type of medication in the treatment of many chronic lung diseases. In fact, they play a big role in both the chronic ‘controller’ treatment as well as in the acute ‘rescue’ treatment during sudden attacks or flare-ups known as exacerbations.
Knowing who and how many people currently have the virus versus those who’ve already had the virus but have now recovered from it might provide important information that will guide our communities, public health systems and governments as we move forward through this pandemic.